1. Home
  2. OFIX vs DAWN Comparison

OFIX vs DAWN Comparison

Compare OFIX & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFIX
  • DAWN
  • Stock Information
  • Founded
  • OFIX 1987
  • DAWN 2018
  • Country
  • OFIX United States
  • DAWN United States
  • Employees
  • OFIX N/A
  • DAWN N/A
  • Industry
  • OFIX Medical/Dental Instruments
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • OFIX Health Care
  • DAWN Health Care
  • Exchange
  • OFIX Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • OFIX 564.4M
  • DAWN 624.8M
  • IPO Year
  • OFIX N/A
  • DAWN 2021
  • Fundamental
  • Price
  • OFIX $14.54
  • DAWN $7.19
  • Analyst Decision
  • OFIX Strong Buy
  • DAWN Strong Buy
  • Analyst Count
  • OFIX 5
  • DAWN 7
  • Target Price
  • OFIX $21.75
  • DAWN $27.86
  • AVG Volume (30 Days)
  • OFIX 270.8K
  • DAWN 1.4M
  • Earning Date
  • OFIX 11-06-2025
  • DAWN 10-29-2025
  • Dividend Yield
  • OFIX N/A
  • DAWN N/A
  • EPS Growth
  • OFIX N/A
  • DAWN N/A
  • EPS
  • OFIX N/A
  • DAWN N/A
  • Revenue
  • OFIX $809,030,000.00
  • DAWN $187,638,000.00
  • Revenue This Year
  • OFIX $3.88
  • DAWN $12.96
  • Revenue Next Year
  • OFIX $5.59
  • DAWN $48.40
  • P/E Ratio
  • OFIX N/A
  • DAWN N/A
  • Revenue Growth
  • OFIX 4.84
  • DAWN 2190.50
  • 52 Week Low
  • OFIX $10.24
  • DAWN $5.64
  • 52 Week High
  • OFIX $20.73
  • DAWN $16.76
  • Technical
  • Relative Strength Index (RSI)
  • OFIX 52.43
  • DAWN 50.39
  • Support Level
  • OFIX $13.99
  • DAWN $7.14
  • Resistance Level
  • OFIX $14.42
  • DAWN $7.73
  • Average True Range (ATR)
  • OFIX 0.40
  • DAWN 0.36
  • MACD
  • OFIX -0.06
  • DAWN 0.02
  • Stochastic Oscillator
  • OFIX 56.02
  • DAWN 33.44

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: